Tema ETFs’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,388
Closed -$283K 173
2024
Q4
$283K Buy
+3,388
New +$278K 0.12% 131

Other funds holding ITCI

Tema ETFs's ITCI Position: Q1 2025 in Review

Tema ETFs sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 3,388 shares — an estimated $283K sold.

Tema ETFs first reported a position in ITCI in Q4 2024 and held it in 1 quarter. The position peaked at $283K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Tema ETFs reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Tema ETFs sold 3,388 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $283K.
  • Tema ETFs first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 1 quarter.
  • Tema ETFs's Intra-Cellular Therapies Inc. position peaked at $283K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Tema ETFs's 13F filing for Q1 2025, filed 14 May 2025.